{"id":68788,"date":"2013-08-18T09:41:35","date_gmt":"2013-08-18T08:41:35","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=2713"},"modified":"2013-08-18T09:41:35","modified_gmt":"2013-08-18T08:41:35","slug":"fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/","title":{"rendered":"&#8220;Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions&#8221;"},"content":{"rendered":"<p><b><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/08\/josepllop1.jpg\"><img decoding=\"async\" class=\"alignleft\" alt=\"josepllop\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/08\/josepllop1.jpg\" width=\"115\" height=\"152\" \/><\/a><\/b><span style=\"color: #888888;\"><strong>El farmac\u00e8utic Josep Llop \u00e9s el coordinador d\u2019un grup de recerca a l\u2019<span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.idibell.cat\/ca\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #888888; text-decoration: underline;\">IDIBELL<\/span><\/a><\/span> (Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge) format majorit\u00e0riament per farmac\u00e8utics. Llop, tamb\u00e9 vocal de la Junta de Govern del COFB, ens ha explicat en quins \u00e0mbits i projectes treballa actualment aquest grup i en quin marc s\u2019emmarca aquest treball.<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><b><br \/>\nQuin \u00e9s el paper dels farmac\u00e8utics en el grup de Recerca que coordines a l\u2019IDIBELL? <\/b><\/p>\n<p>El grup que coordino est\u00e0 format per 18 investigadors dels quals 16 s\u00f3n farmac\u00e8utics, m\u00e9s un bi\u00f2leg i un qu\u00edmic. De fet, a Catalunya \u00e9s l\u2019\u00fanic <b>grup de recerca integrat en un institut biom\u00e8dic acreditat que per la seva tem\u00e0tica i composici\u00f3 \u00e9s d\u2019\u00e0mbit farmac\u00e8utic<\/b>.\u00a0 A l\u2019estat espanyol nom\u00e9s hi ha un grup similar que est\u00e0 integrat a l\u2019institut d\u2019investigaci\u00f3 sanit\u00e0ria Gregorio Mara\u00f1\u00f3n de Madrid. Aquesta situaci\u00f3 no implica que no hi hagi farmac\u00e8utics que individualment estiguin integrats en altres grups de recerca tamb\u00e9 acreditats.<\/p>\n<p>El grup est\u00e0 constitu\u00eft per membres de l\u2019Hospital Universitari de Bellvitge (HUB) i de la Universitat de Barcelona (UB). \u00a0L&#8217;HUB participa amb els Serveis de Farm\u00e0cia i de Bioqu\u00edmica i la UB amb el Servei de Desenvolupament del Medicament (SDM) i amb la Unitat de Biofarm\u00e0cia i Farmacocin\u00e8tica (UBIF), ambd\u00f3s de la Facultat de Farm\u00e0cia.<\/p>\n<p>Des de l&#8217;HUB el Servei de Farm\u00e0cia incorpora 10 investigadors de les \u00e0rees de Nutrici\u00f3 Artificial, Farmacot\u00e8cnia i Farmacocin\u00e8tica i el servei de Bioqu\u00edmica, 3 investigadors de l\u2019\u00e0rea de Farmacogen\u00e8tica. Des de la UB, l\u2019SDM incorpora 5 investigadors en l\u2019\u00e0mbit de la Tecnologia Farmac\u00e8utica i la UBIF, 1 investigadora en l\u2019\u00e0mbit de la Farmacocin\u00e8tica poblacional. Els responsables de les diferents \u00e0rees s\u00f3n: el Dr. Josep M\u00aa Su\u00f1\u00e9-Negre per a Tecnologia farmac\u00e8utica, el Dr. Pedro Alia en Farmacogen\u00e8tica, la Dra. Helena Colom en Farmacocin\u00e8tica poblacional i la Dra. Maria Badia en Nutrici\u00f3 artificial.<\/p>\n<p>&nbsp;<\/p>\n<p><b>Quins projectes esteu realitzant actualment? <\/b><\/p>\n<p>El nostre grup treballa en diferents l\u00ednies ja acordades pr\u00e8viament amb l\u2019IDIBELL. Entre els darrers projectes cal destacar els diferents estudis farmacocin\u00e8tics i farmacogen\u00e8tics d\u2019anticossos monoclonals (f\u00e0rmacs anti-TNF\u03b1) en diferents situacions cl\u00edniques com s\u00f3n l\u2019artritis reumat\u00f2ide, malaltia inflamat\u00f2ria intestinal i la psoriasi. L\u2019objectiu dels diferents estudis \u00e9s establir models poblacionals que permetin personalitzar els tractaments en un \u00e0mbit on la variabilitat cl\u00ednica i la manca de resposta \u00e9s elevada.<\/p>\n<p>En l\u2019esfera de la <b>tecnologia<\/b>, estem treballant en l\u2019aplicaci\u00f3 de nanotecnologia per al transport i vehiculitzaci\u00f3 de pl\u00e0smids (DNA-RNA). Es tracta d\u2019una recerca en el desenvolupament de nanoesferes i\/o nanoc\u00e0psules de DNA i de Si-RNA per assolir que puguin arribar a c\u00e8l\u00b7lula diana despr\u00e9s de la seva administraci\u00f3, la qual cosa ens dur\u00e0 a cercar la millor forma farmac\u00e8utica per poder-ho fer. En aquest context, estem investigant l&#8217;aplicaci\u00f3 de diferents pol\u00edmers biodegradables i biocompatibles per a fer nanoesferes\/nanoc\u00e0psules que permetin dirigir-lo cap a la c\u00e8l\u00b7lula diana, possibilitar que travessi la membrana cel\u00b7lular, entri a l&#8217;interior de la c\u00e8l\u00b7lula i s&#8217;alliberi del pol\u00edmer transportador i s&#8217;expressi per desenvolupar la seva acci\u00f3 (tractament c\u00e0ncer i tractament VIH).<\/p>\n<p>En l\u2019\u00e0mbit de la <b>nutrici\u00f3 artificial<\/b> estem treballant en la utilitzaci\u00f3 de farmaconutrients amb capacitat immunomoduladora per via venosa i altes dosis en pacients sotmesos a cirurgia major que en funci\u00f3 dels resultats ampliar\u00edem a pacients amb insufici\u00e8ncia renal i hemofiltraci\u00f3. L\u2019objectiu \u00e9s millorar la resposta inflamat\u00f2ria sist\u00e8mica d\u2019aquests pacients en situaci\u00f3 post-agressi\u00f3.<\/p>\n<p>Independentment d\u2019aquestes l\u00ednies, el grup participa i d\u00f3na suport a l\u2019\u00e0rea de<b> farmacoter\u00e0pia <\/b>per a fer recerca en l\u2019\u00e0mbit del medicament conjuntament amb altres grups de l\u2019IDIBELL.\u00a0 Estem col\u00b7laborant en dos assajos cl\u00ednics, un amb medicina intensiva i l&#8217;altre amb infect\u00f2legs en l\u2019estudi per a l\u2019optimitzaci\u00f3 de la ter\u00e0pia amb antibi\u00f2tics beta-lact\u00e0mics i carbapenems en pacients cr\u00edtics i, un altre assaig, amb investigadors del grup del dolor en el tractament local de les cures que cursen amb dolor.<\/p>\n<p>&nbsp;<\/p>\n<p><b>Com est\u00e0 canviant el paper del farmac\u00e8utic en recerca?<\/b> <b>Quins reptes t\u00e9 el farmac\u00e8utic en aquest \u00e0mbit?<\/b><\/p>\n<p>La creaci\u00f3 del grup va ser una aposta estrat\u00e8gica del Servei de Farm\u00e0cia de l\u2019Hospital de Bellvitge, que dirigeix el Dr. Ramon Jodar. Varem comen\u00e7ar l\u2019any 2011, per tant en aquest sentit som un grup emergent.<\/p>\n<p>La nostra aposta representa un canvi qualitatiu, el temps dir\u00e0 si aporta o no avantatges. El principal repte \u00e9s que et fa jugar en unes regles de joc amb marcat car\u00e0cter competitiu, at\u00e8s que cada any hem de passar una avaluaci\u00f3 de projectes i treballs realitzats. Entrar en el grup implica una s\u00e8rie de requisits i habilitats establertes per l\u2019institut biom\u00e8dic.<\/p>\n<p>Fins ara el farmac\u00e8utic hospitalari, com a grup, treballava en un \u00e0mbit molt corporatiu. El que nosaltres apostem \u00e9s per treballar en un \u00e0mbit m\u00e9s obert, que potser comporta riscos per\u00f2 tamb\u00e9 oportunitats. En definitiva \u00e9s una aposta de futur que passa per donar joc a les noves generacions.<\/p>\n<p><b>\u00a0<\/b><\/p>\n<p><b>Com afecta l\u2019entorn econ\u00f2mic actual a la recerca? Quines alternatives hi ha? <\/b><\/p>\n<p>L\u2019entorn econ\u00f2mic \u00e9s cabdal en l\u2019\u00e0mbit de recerca i en aquest sentit, sens dubte, hem triat el pitjor moment per sortir a fer recerca competitiva, at\u00e8s que aquesta dep\u00e8n dels recursos. El pitjor de tot \u00e9s com aquesta situaci\u00f3 de desinversi\u00f3 est\u00e0 afectant al nostre futur, els joves investigadors. Aquest segment de professionals \u00e9s el que t\u00e9 un nivell m\u00e9s alt de precarietat laboral i necessitem eines per a fidelitzar-los. La recerca requereix horitzons estables.<\/p>\n<p>Pel que fa a oportunitats en temps de crisi, intentem ser innovadors donant prioritats a projectes amb retorn. Per aquest motiu la nostra estrat\u00e8gia passa per ser competitius en nius d\u2019activitat de mercat i empresarial en qu\u00e8 hi ha una demanda poc coberta. En aquest context, pensem que l\u2019aposta pel desenvolupament en tecnologia farmac\u00e8utica pot ser de gran ajuda.<\/p>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_2719\" aria-describedby=\"caption-attachment-2719\" style=\"width: 544px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/08\/grupfarmacoterapia-idibell.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-2719  \" title=\"El grup Farmacoter\u00e0pia, farmacogen\u00e8tica i tecnologia farmac\u00e8utic\" alt=\"grupfarmacoterapia-idibell\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/08\/grupfarmacoterapia-idibell.jpg\" width=\"544\" height=\"362\" \/><\/a><figcaption id=\"caption-attachment-2719\" class=\"wp-caption-text\">El grup Farmacoter\u00e0pia, farmacogen\u00e8tica i tecnologia farmac\u00e8utica est\u00e0 integrat a l\u2019Institut Biom\u00e8dic de Bellvitge (IDIBELL), un institut biom\u00e8dic per a la recerca b\u00e0sica i traslacional que t\u00e9 57 grups acreditats per a la recerca. Va ser creat l\u2019any 2004 a partir de la fusi\u00f3 de diverses entitats d\u2019investigaci\u00f3, participat per l\u2019Hospital Universitari de Bellvitge, l\u2019Institut Catal\u00e0 d\u2019Oncologia i la Universitat de Barcelona.<br \/>L&#8217;any 2009, l\u2019IDIBELL es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. Actualment n\u2019hi ha 18 instituts (5 catalans).<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El farmac\u00e8utic Josep Llop \u00e9s el coordinador d\u2019un grup de recerca a l\u2019IDIBELL (Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge) format majorit\u00e0riament per farmac\u00e8utics. Llop, tamb\u00e9 vocal de la Junta de Govern del COFB, ens ha explicat en quins \u00e0mbits i projectes treballa actualment aquest grup i en quin marc s\u2019emmarca aquest [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2719,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,32],"tags":[844],"class_list":["post-68788","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-noticies-farmacia","tag-recerca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>&quot;Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions&quot; - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"&quot;Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions&quot; - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El farmac\u00e8utic Josep Llop \u00e9s el coordinador d\u2019un grup de recerca a l\u2019IDIBELL (Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge) format majorit\u00e0riament per farmac\u00e8utics. Llop, tamb\u00e9 vocal de la Junta de Govern del COFB, ens ha explicat en quins \u00e0mbits i projectes treballa actualment aquest grup i en quin marc s\u2019emmarca aquest [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-08-18T08:41:35+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"&#8220;Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions&#8221;\",\"datePublished\":\"2013-08-18T08:41:35+00:00\",\"dateModified\":\"2013-08-18T08:41:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/\"},\"wordCount\":1204,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Recerca\"],\"articleSection\":[\"Destacats\",\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/\",\"name\":\"\\\"Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions\\\" - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-08-18T08:41:35+00:00\",\"dateModified\":\"2013-08-18T08:41:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"&#8220;Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions&#8221;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\"Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions\" - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/","og_locale":"ca_ES","og_type":"article","og_title":"\"Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions\" - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El farmac\u00e8utic Josep Llop \u00e9s el coordinador d\u2019un grup de recerca a l\u2019IDIBELL (Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge) format majorit\u00e0riament per farmac\u00e8utics. Llop, tamb\u00e9 vocal de la Junta de Govern del COFB, ens ha explicat en quins \u00e0mbits i projectes treballa actualment aquest grup i en quin marc s\u2019emmarca aquest [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-08-18T08:41:35+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"&#8220;Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions&#8221;","datePublished":"2013-08-18T08:41:35+00:00","dateModified":"2013-08-18T08:41:35+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/"},"wordCount":1204,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#primaryimage"},"thumbnailUrl":"","keywords":["Recerca"],"articleSection":["Destacats","Not\u00edcies farm\u00e0cia"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/","url":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/","name":"\"Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions\" - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-08-18T08:41:35+00:00","dateModified":"2013-08-18T08:41:35+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/18\/fer-recerca-en-un-ambit-mes-obert-comporta-riscos-pero-tambe-oportunitats-i-passa-per-donar-joc-als-mes-joves\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"&#8220;Fer recerca en un \u00e0mbit m\u00e9s obert comporta riscos per\u00f2 tamb\u00e9 oportunitats i passa per donar joc a les noves generacions&#8221;"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El farmac\u00e8utic Josep Llop \u00e9s el coordinador d\u2019un grup de recerca a l\u2019IDIBELL (Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge) format majorit\u00e0riament per farmac\u00e8utics. Llop, tamb\u00e9 vocal de la Junta de Govern del COFB, ens ha explicat en quins \u00e0mbits i projectes treballa actualment aquest grup i en quin marc s\u2019emmarca aquest [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/68788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=68788"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/68788\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=68788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=68788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=68788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}